Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1764-1777

  Zhang, Weijuan ^a   Xu, Wei ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERUM AMYLOID P;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; DNA IMMUNIZATION; DRUG MECHANISM; ENZYME ACTIVATION; EX VIVO STUDY; FEMALE; IMMUNOPATHOGENESIS; IN VIVO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOPTIVE TRANSFER; ANIMALS; CELL LINE; DNA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; INTERLEUKIN-10; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED BALB C; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SERUM AMYLOID P-COMPONENT; SIGNAL TRANSDUCTION;

EID: 80051921285     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002315     Document Type: Article

References (66)

1. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939. (Pubitemid 351397092)
2. Paulson, J. C. 2007. Innate immune response triggers lupus-like autoimmune disease. Cell 130: 589-591. (Pubitemid 47268067)
3. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306. (Pubitemid 26160701)
4. Davidson, A., and B. Diamond. 2001. Autoimmune diseases. N. Engl. J. Med. 345: 340-350.
5. McClain, M. T., L. D. Heinlen, G. J. Dennis, J. Roebuck, J. B. Harley, and J. A. James. 2005. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11: 85-89. (Pubitemid 40215842)
6. Gandhi, R., E. Hussain, J. Das, R. Handa, and R. Pal. 2006. Anti-idiotype-mediated epitope spreading and diminished phagocytosis by a human monoclonal antibody recognizing late-stage apoptotic cells. Cell Death Differ. 13: 1715-1726. (Pubitemid 44390859)
7. Chang, N. H., T. McKenzie, G. Bonventi, C. Landolt-Marticorena, P. R. Fortin, D. Gladman, M. Urowitz, and J. E. Wither. 2008. Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus. J. Immunol. 180: 1276-1284.
8. Humrich, J. Y., H. Morbach, R. Undeutsch, P. Enghard, S. Rosenberger, O. Weigert, L. Kloke, J. Heimann, T. Gaber, S. Brandenburg, et al. 2010. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc. Natl. Acad. Sci. USA 107: 204-209.
9. Shlomchik, M. J., A. Marshak-Rothstein, C. B. Wolfowicz, T. L. Rothstein, and M. G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805-811. (Pubitemid 17118532)
10. Hahn, B. H. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368. (Pubitemid 28216666)
11. Vinuesa, C. G., and C. C. Goodnow. 2002. Immunology: DNA drives autoimmunity. Nature 416: 595-598.
12. Qiao, B., J. Wu, Y. W. Chu, Y. Wang, D. P. Wang, H. S. Wu, and S. D. Xiong. 2005. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA. Rheumatology (Oxford) 44: 1108-1114. (Pubitemid 41236016)
13. Wen, Z. K., W. Xu, L. Xu, Q. H. Cao, Y. Wang, Y. W. Chu, and S. D. Xiong. 2007. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46: 1796-1803. (Pubitemid 350168294)
14. Zhang, W., W. Xu, and S. Xiong. 2010. Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J. Immunol. 184: 6465-6478.
15. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330. (Pubitemid 24091790)
16. Qian, Y., K. L. Conway, X. Lu, H. M. Seitz, G. K. Matsushima, and S. H. Clarke. 2006. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood 108: 974-982. (Pubitemid 44154633)
17. Walport, M. J. 2000. Lupus, DNase and defective disposal of cellular debris. Nat. Genet. 25: 135-136. (Pubitemid 30394978)
18. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196: 135-140. (Pubitemid 34747319)
19. Napirei, M., H. Karsunky, B. Zevnik, H. Stephan, H. G. Mannherz, and T. Möröy. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25: 177-181. (Pubitemid 30394988)
20. Bickerstaff, M. C., M. Botto, W. L. Hutchinson, J. Herbert, G. A. Tennent, A. Bybee, D. A. Mitchell, H. T. Cook, P. J. Butler, M. J. Walport, and M. B. Pepys. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5: 694-697. (Pubitemid 29289434)
21. Sørensen, I. J., E. Holm Nielsen, L. Schrøder, A. Voss, L. Horváth, and S. E. Svehag. 2000. Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients. J. Clin. Immunol. 20: 408-415. (Pubitemid 32099705)
22. Garlanda, C., B. Bottazzi, A. Bastone, and A. Mantovani. 2005. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23: 337-366. (Pubitemid 40563173)
23. Pepys, M. B., and P. J. Butler. 1987. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148: 308-313. (Pubitemid 17146323)
24. Mold, C., H. D. Gresham, and T. W. Du Clos. 2001. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. J. Immunol. 166: 1200-1205. (Pubitemid 32060280)
25. Lu, J., L. L. Marnell, K. D. Marjon, C. Mold, T.W. Du Clos, and P. D. Sun. 2008. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456: 989-992.
26. Bottazzi, B., A. Doni, C. Garlanda, and A. Mantovani. 2010. An integrated view of humoral innate immunity: Pentraxins as a paradigm. Annu. Rev. Immunol. 28: 157-183.
27. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
28. Erwig, L. P., and P. M. Henson. 2007. Immunological consequences of apoptotic cell phagocytosis. Am. J. Pathol. 171: 2-8.
29. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat. Immunol. 11: 889-896.
30. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593-604.
31. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686. (Pubitemid 39457982)
32. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555. (Pubitemid 35223554)
33. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
34. Yang, C. S., C. H. Song, J. S. Lee, S. B. Jung, J. H. Oh, J. Park, H. J. Kim, J. K. Park, T. H. Paik, and E. K. Jo. 2006. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages. Cell. Microbiol. 8: 1158-1171. (Pubitemid 43871650)
35. Ito, T., M. Schaller, C. M. Hogaboam, T. J. Standiford, M. Sandor, N.W. Lukacs, S. W. Chensue, and S. L. Kunkel. 2009. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DCderived Notch ligand delta-like 4. J. Clin. Invest. 119: 33-46.
36. Lake, F. R., P. W. Noble, P. M. Henson, and D. W. Riches. 1994. Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha. J. Clin. Invest. 93: 1661-1669. (Pubitemid 24116406)
37. Pepys, M. B. 1979. Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology 37: 637-641. (Pubitemid 9227124)
38. Taktak, Y. S., and B. Stenning. 1992. Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera. Horm. Metab. Res. 24: 371-374.
39. Hawkins, P. N., G. A. Tennent, P. Woo, and M. B. Pepys. 1991. Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin. Exp. Immunol. 84: 308-316.
40. Hawkins, P. N., R. Wootton, and M. B. Pepys. 1990. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J. Clin. Invest. 86: 1862-1869.
41. Estabrook, M. M., D. L. Jack, N. J. Klein, and G. A. Jarvis. 2004. Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. J. Immunol. 172: 3784-3792. (Pubitemid 38337963)
42. Gao, B., Z. Duan, W. Xu, and S. Xiong. 2009. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50: 424-433.
43. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117: 175-184. (Pubitemid 46048464)
44. Perez, O. D., and G. P. Nolan. 2002. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 20: 155-162. (Pubitemid 34158031)
45. Chung, E. Y., J. Liu, Y. Homma, Y. Zhang, A. Brendolan, M. Saggese, J. Han, R. Silverstein, L. Selleri, and X. Ma. 2007. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27: 952-964. (Pubitemid 350251222)
46. Hutcheson, J., J. C. Scatizzi, A. M. Siddiqui, G. K. Haines, III, T. Wu, Q. Z. Li, L. S. Davis, C. Mohan, and H. Perlman. 2008. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217. (Pubitemid 351215233)
47. Li, K., W. Xu, Q. Guo, Z. Jiang, P. Wang, Y. Yue, and S. Xiong. 2009. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 105: 353-364.
48. Hunter, M. M., A. Wang, K. S. Parhar, M. J. Johnston, N. Van Rooijen, P. L. Beck, and D. M. McKay. 2010. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138: 1395-1405.
49. Katakura, T., M. Miyazaki, M. Kobayashi, D. N. Herndon, and F. Suzuki. 2004. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172: 1407-1413. (Pubitemid 38116782)
50. Yin, Z., G. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M. E. Robert, J. McNiff, M. P. Madaio, and J. Craft. 2002. IL-10 regulates murine lupus. J. Immunol. 169: 2148-2155. (Pubitemid 34857682)
51. Roszer, T., M. P. Menéndez-Gutiérrez, M. I. Lefterova, D. Alameda, V. Núñez, M. A. Lazar, T. Fischer, and M. Ricote. 2011. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J. Immunol. 186: 621-631.
52. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975. (Pubitemid 37323217)
53. Mevorach, D., J. L. Zhou, X. Song, and K. B. Elkon. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188: 387-392. (Pubitemid 28357766)
54. Pisetsky, D. S. 1996. The immunologic properties of DNA. J. Immunol. 156: 421-423. (Pubitemid 26028897)
55. Mukundan, L., J. I. Odegaard, C. R. Morel, J. E. Heredia, J. W. Mwangi, R. R. Ricardo-Gonzalez, Y. P. Goh, A. R. Eagle, S. E. Dunn, J. U. Awakuni, et al. 2009. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat. Med. 15: 1266-1272.
56. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607. (Pubitemid 34406754)
57. Okabe, Y., K. Kawane, S. Akira, T. Taniguchi, and S. Nagata. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202: 1333-1339. (Pubitemid 41668736)
58. Gillmore, J. D., W. L. Hutchinson, J. Herbert, A. Bybee, D. A. Mitchell, R. P. Hasserjian, K. Yamamura, M. Suzuki, C. A. Sabin, and M. B. Pepys. 2004. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology 112: 255-264. (Pubitemid 38703572)
59. Bygrave, A. E., K. L. Rose, J. Cortes-Hernandez, J. Warren, R. J. Rigby, H. T. Cook, M. J. Walport, T. J. Vyse, and M. Botto. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2: E243.
60. Tamaoki, T., H. Tezuka, Y. Okada, S. Ito, H. Shimura, M. Sakamoto, T. Endo, Y. Ozaki, S. Kanba, and S. Maeda. 2005. Avoiding the effect of linked genes is crucial to elucidate the role of Apcs in autoimmunity. Nat. Med. 11: 11-12, author reply 12-13.
61. Breathnach, S. M., H. Kofler, N. Sepp, J. Ashworth, D. Woodrow, M. B. Pepys, and H. Hintner. 1989. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 170: 1433-1438. (Pubitemid 19250706)
62. Wang, Y., Y. Guo, X. Wang, J. Huang, J. Shang, and S. Sun. 2011. Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines. J. Immunol. 186: 2860-2870.
63. Schiffer, L., R. Bethunaickan, M. Ramanujam, W. Huang, M. Schiffer, H. Tao, M. P. Madaio, E. P. Bottinger, and A. Davidson. 2008. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. [Published erratum appears in 2008 J. Immunol. 180: 3613.] J. Immunol. 180: 1938-1947.
64. Ponomarev, E. D., K. Maresz, Y. Tan, and B. N. Dittel. 2007. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci. 27: 10714-10721. (Pubitemid 47535871)
65. Lucas, M., X. Zhang, V. Prasanna, and D. M. Mosser. 2005. ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol. 175: 469-477. (Pubitemid 40884351)
66. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.